1. Home
  2. CADL vs PKBK Comparison

CADL vs PKBK Comparison

Compare CADL & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$4.99

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Logo Parke Bancorp Inc.

PKBK

Parke Bancorp Inc.

N/A

Current Price

$31.36

Market Cap

378.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
PKBK
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.8M
378.6M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
CADL
PKBK
Price
$4.99
$31.36
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $17.67
N/A
AVG Volume (30 Days)
★ 1.4M
25.3K
Earning Date
11-12-2026
10-21-2026
Dividend Yield
N/A
★ 2.55%
EPS Growth
★ 58.62
39.21
EPS
N/A
★ 3.04
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.35
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$22.09
52 Week High
$14.00
$35.70

Technical Indicators

Market Signals
Indicator
CADL
PKBK
Relative Strength Index (RSI) 25.65 32.18
Support Level $4.62 $29.95
Resistance Level $5.51 $31.35
Average True Range (ATR) 0.70 0.99
MACD -0.33 -0.15
Stochastic Oscillator 1.62 14.73

Price Performance

Historical Comparison
CADL
PKBK

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About PKBK Parke Bancorp Inc.

Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending, among others. The company operates one reportable segment of business, community banking.

Share on Social Networks: